Abstract
ObjectiveTo examine the clinical and serological features of ankylosing spondylitis (AS) patients treated with tumour necrosis factor (TNF) inhibitors (TNFi).MethodsConsecutive, unselected AS patients commencing TNFi were prospectively studied between 2004...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
